Literature DB >> 17512910

Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS.

Svitlana Garbuzova-Davis1, Edward Haller, Samuel Saporta, Irina Kolomey, Santo V Nicosia, Paul R Sanberg.   

Abstract

The purpose of this study was to determine the ultrastructure of the blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB) in G93A SOD1 mice modeling ALS at different stages of disease. Electron microscope examination of brainstem, cervical and lumbar spinal cords was performed in ALS mice at early and late stages of disease. Our results show disorganized mitochondrial cristae and degenerating mitochondria in endothelial cells and neuropil, swollen astrocyte foot processes, swollen and degenerating capillary endothelial cells, astrocytes and motor neurons and extensive extracellular edema. In spite of progressive extracellular edema in neural tissue, capillary endothelial cell tight junctions appeared to remain intact in early and late symptomatic animals. Results show that disruption of BBB and BSCB was evident in areas of motor neuron degeneration in G93A mice at both early and late stages of disease. Capillary rupture was observed in brainstem in early symptomatic G93A mice. Capillary ultrastructure revealed that endothelial cell membrane and/or basement membrane damage occurred, followed by vascular leakage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512910     DOI: 10.1016/j.brainres.2007.04.044

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  74 in total

1.  Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration.

Authors:  Sebastian A Lewandowski; Ingrid Nilsson; Linda Fredriksson; Peter Lönnerberg; Lars Muhl; Manuel Zeitelhofer; Milena Z Adzemovic; Susanne Nichterwitz; Daniel A Lawrence; Eva Hedlund; Ulf Eriksson
Journal:  Acta Neuropathol       Date:  2015-12-19       Impact factor: 17.088

2.  Metalloproteinase alterations in the bone marrow of ALS patients.

Authors:  Patrizia Bossolasco; Lidia Cova; Cinzia Calzarossa; Federica Servida; Niccolò Emanuele Mencacci; Francesco Onida; Elio Polli; Giorgio Lambertenghi Deliliers; Vincenzo Silani
Journal:  J Mol Med (Berl)       Date:  2010-01-21       Impact factor: 4.599

Review 3.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

Review 4.  Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury.

Authors:  Charles Nicaise; Dinko Mitrecic; Aditi Falnikar; Angelo C Lepore
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

5.  Immunological aspects in amyotrophic lateral sclerosis.

Authors:  Maria Carolina O Rodrigues; Júlio C Voltarelli; Paul R Sanberg; Cesario V Borlongan; Svitlana Garbuzova-Davis
Journal:  Transl Stroke Res       Date:  2012-05-03       Impact factor: 6.829

Review 6.  Brain metabolism in health, aging, and neurodegeneration.

Authors:  Simonetta Camandola; Mark P Mattson
Journal:  EMBO J       Date:  2017-04-24       Impact factor: 11.598

Review 7.  Physical activity and neuroprotection in amyotrophic lateral sclerosis.

Authors:  Mary E McCrate; Brian K Kaspar
Journal:  Neuromolecular Med       Date:  2008-02-20       Impact factor: 3.843

8.  ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration.

Authors:  Zhihui Zhong; Rashid Deane; Zarina Ali; Margaret Parisi; Yuriy Shapovalov; M Kerry O'Banion; Konstantin Stojanovic; Abhay Sagare; Severine Boillee; Don W Cleveland; Berislav V Zlokovic
Journal:  Nat Neurosci       Date:  2008-03-16       Impact factor: 24.884

9.  Reduction of circulating endothelial cells in peripheral blood of ALS patients.

Authors:  Svitlana Garbuzova-Davis; Robert L Woods; Michael K Louis; Theresa A Zesiewicz; Nicole Kuzmin-Nichols; Kelly L Sullivan; Amber M Miller; Diana G Hernandez-Ontiveros; Paul R Sanberg
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

Review 10.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.